Pfizer Q4 Earnings Eke Out Unexpected Profit Despite Lower COVID Product Sales
Pfizer’s fourth quarter earnings revealed a surprise profit despite a sizable revenue contraction as sales of COVID-related products slowed.
Symbol | Last Price | Change | % Change |
---|---|---|---|